MARKHAM, ON, July 24, 2018 /CNW/ – MedReleaf Corp. today announced that it has acquired MED Colombia SAS, a company with licences in Colombia to cultivate cannabis and produce cannabis oil extracts, along with a library of cannabis genetics, for a total consideration of €2.75 million in cash. This acquisition provides MedReleaf with the ability to produce low-cost, high-quality raw materials to serve its global supply chain as well as the domestic Colombian medical cannabis market.
Full Article: newswire.ca